Perrigo (NYSE:PRGO – Get Free Report) and Orion OYJ (OTCMKTS:ORINY – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.
Insider & Institutional Ownership
95.9% of Perrigo shares are held by institutional investors. 0.4% of Perrigo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Volatility & Risk
Perrigo has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Orion OYJ has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.
Earnings and Valuation
This table compares Perrigo and Orion OYJ”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Perrigo | $4.09 billion | 0.55 | -$1.43 billion | ($12.76) | -1.27 |
| Orion OYJ | $2.14 billion | 7.63 | $566.04 million | $2.71 | 21.32 |
Orion OYJ has lower revenue, but higher earnings than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Orion OYJ, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Perrigo and Orion OYJ’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Perrigo | -43.27% | 12.39% | 4.07% |
| Orion OYJ | 30.25% | 54.09% | 33.33% |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Perrigo and Orion OYJ, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Perrigo | 2 | 3 | 1 | 0 | 1.83 |
| Orion OYJ | 0 | 1 | 0 | 1 | 3.00 |
Perrigo currently has a consensus target price of $18.50, indicating a potential upside of 14.44%. Given Perrigo’s higher probable upside, equities research analysts plainly believe Perrigo is more favorable than Orion OYJ.
Dividends
Perrigo pays an annual dividend of $1.16 per share and has a dividend yield of 7.2%. Orion OYJ pays an annual dividend of $0.36 per share and has a dividend yield of 0.6%. Perrigo pays out -9.1% of its earnings in the form of a dividend. Orion OYJ pays out 13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Perrigo has raised its dividend for 23 consecutive years. Perrigo is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
About Perrigo
Perrigo is a global consumer healthcare company that develops, manufactures and markets over-the-counter medicines and other self-care products. Its offerings include treatments for allergies, coughs and colds, pain and digestive health, as well as skin care, oral care and infant nutrition products. The company supplies both its own consumer brands and store-brand products, which retailers sell under their own labels. Perrigo serves customers primarily in North America and Europe through retail and other healthcare channels.
About Orion OYJ
Orion Oyj is a Finnish pharmaceutical company that develops, manufactures and markets medicines for human and veterinary use. Its portfolio includes prescription and over-the-counter medicines, as well as active pharmaceutical ingredients supplied to other pharmaceutical companies. Founded in 1917 and headquartered in Espoo, Finland, Orion has a long history in the pharmaceutical industry. The company focuses on areas including oncology, neurology and respiratory diseases, and develops some products in collaboration with international pharmaceutical partners.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
